Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans

• 收藏
• 分享

专利权人:

Robert Salantinjants;Aida Salatinjants

发明人:

Aida Salatinjants,Robert Salantinjants

申请号：

US13709381

公开号：

US20130158048A1

申请日:

2012.12.10

申请国别(地区):

US

年份:

2013

代理人:

摘要：

In the method of administering rifampicin to a human subject, the improvement wherein a prolongation composition is also administered, said prolongation composition comprising:Pectin0.94gPotassium bitartrate0.48gTannic acid0.8gL-Tyrosine0.21gRiboflavin2 ml 10% solution of 15% Ethyl AlcoholHexanoic Acid (Caproic acid)0.06mlEthyl Alcohol15% Ethyl Alcohol to make 100 ml

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/